Classification and treatment strategy for Moyamoya disease-related aneurysms

Yangchun Hu1, Xiaojian Wang1, Chao Li1

  • 1Department of Neurosurgery, The First Affiliated Hospital of Anhui Medical University, Jixi 218, Hefei, 230022, People's Republic of China.

PubMed
Abstract

Insights

Moyamoya disease with intracranial aneurysms (MMD-IA) presents diverse clinical features. Individualized neurosurgical treatments based on aneurysm location are crucial for successful outcomes in MMD-IA patients.

Area of Science:

  • Neurology
  • Neurosurgery
  • Vascular Neurology

Background:

  • Moyamoya disease (MMD) involves progressive stenosis of the distal internal carotid artery.
  • Hemodynamic changes in MMD can lead to the comorbidity of intracranial aneurysms (IA).
  • This study investigates the clinical characteristics and treatment of Moyamoya disease with intracranial aneurysms (MMD-IA).

Purpose of the Study:

  • To analyze the clinical presentations of MMD-IA patients.
  • To evaluate therapeutic strategies for MMD-IA.
  • To determine optimal treatment approaches based on aneurysm location.

Main Methods:

  • Retrospective review of 13 MMD-IA patients presenting with intracranial hemorrhage.
  • Analysis of surgical technique notes for all patients.
  • Categorization of aneurysms based on location: Circle of Willis, collateral anastomosis, or basal ganglia region.

Main Results:

  • Aneurysm locations included Willis circle (10 patients), pericallosal artery (2 patients), and basal ganglia (1 patient).
  • Treatments comprised endovascular embolization (5 patients) and aneurysm clipping (7 patients).
  • One patient with a basal ganglia aneurysm received revascularization; all treatments were successful with satisfactory outcomes at 6-24 months follow-up.

Conclusions:

  • MMD-IA exhibits diverse clinical presentations.
  • Treatment strategies for MMD-IA should be individualized based on specific aneurysm locations.
  • Tailored neurosurgical interventions are essential for managing MMD-IA effectively.

Related Concept Videos

Mitral Regurgitation III: Medical Management01:25

Mitral Regurgitation III: Medical Management

Mitral regurgitation (MR) is characterized by retrograde blood circulation from the left ventricle into the left atrium due to inadequate mitral valve closure. The severity of the condition, symptoms, and underlying cause determine treatment strategies.Monitoring and Pharmacological TreatmentPatients with mild to moderate MR typically do not need immediate intervention but regular monitoring to assess progression and guide treatment. Patients with mild MR should have an echocardiogram every 3-5...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm I: Introduction01:30

Aneurysm I: Introduction

An aortic aneurysm is a localized outpouching or dilation at a weak point in the artery wall. It may involve different parts of the aorta, such as the abdominal aorta, aortic arch, or thoracic aorta.Etiological factorsSeveral disorders are associated with aortic aneurysms.Congenital causes, such as primary connective tissue disorders like Marfan syndrome, impact the integrity and strength of connective tissues, notably affecting the aorta. Marfan syndrome is a genetic disorder that specifically...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...